D-1526-2020 Class II Terminated
FDA drug recall D-1526-2020 was initiated by Calvin Scott & Company, Inc. on Jul 27, 2020 and is designated Class II. Reason for recall: CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches. The recall status is terminated (terminated Apr 11, 2024).
Recall Details
- Product Type
- Drugs
- Report Date
- Aug 26, 2020
- Initiation Date
- Jul 27, 2020
- Termination Date
- Apr 11, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
Product Description
Phentermine HCL GrayYellow capsules, 15mg, packaged in a) 28-count bags and b) 56-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, MFG: Tagi Pharma, South Beloit, IL 61080; NDC 51224-0203-70
Reason for Recall
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Distribution Pattern
Nationwide within the United States
Code Information
Lot #:19197; Exp. Date: 8/20, 9/20, 10/20; 19341, Exp. Date: 1/21
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1526-2020
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026